Fulcrum Capital LLC Grows Stock Position in Align Technology, Inc. $ALGN

Fulcrum Capital LLC lifted its stake in Align Technology, Inc. (NASDAQ:ALGN) by 18.1% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 10,966 shares of the medical equipment provider’s stock after buying an additional 1,684 shares during the period. Fulcrum Capital LLC’s holdings in Align Technology were worth $2,076,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of ALGN. Compagnie Lombard Odier SCmA purchased a new position in shares of Align Technology in the first quarter worth about $32,000. Cromwell Holdings LLC increased its holdings in Align Technology by 2,900.0% during the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 174 shares during the period. Center for Financial Planning Inc. purchased a new position in Align Technology during the 1st quarter valued at about $35,000. SVB Wealth LLC purchased a new position in Align Technology during the 1st quarter valued at about $36,000. Finally, Farther Finance Advisors LLC increased its holdings in Align Technology by 42.2% during the 2nd quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 92 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Stock Performance

Align Technology stock opened at $125.79 on Friday. The stock’s 50 day simple moving average is $135.61 and its two-hundred day simple moving average is $164.40. The stock has a market cap of $9.12 billion, a price-to-earnings ratio of 21.21, a PEG ratio of 1.50 and a beta of 1.70. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $246.19.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the firm posted $2.41 earnings per share. The business’s revenue was down 1.6% compared to the same quarter last year. Align Technology has set its Q3 2025 guidance at EPS. On average, analysts predict that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its Board of Directors has approved a share repurchase program on Tuesday, August 5th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to purchase up to 2% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s leadership believes its stock is undervalued.

Insider Activity at Align Technology

In related news, CEO Joseph M. Hogan purchased 7,576 shares of the company’s stock in a transaction dated Friday, August 1st. The shares were purchased at an average cost of $131.49 per share, with a total value of $996,168.24. Following the transaction, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This trade represents a 4.27% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.66% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

ALGN has been the topic of a number of research analyst reports. Stifel Nicolaus reduced their price target on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a report on Thursday, July 31st. Wells Fargo & Company reduced their price target on Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a report on Thursday, July 31st. Morgan Stanley restated an “equal weight” rating and set a $154.00 price target (down previously from $249.00) on shares of Align Technology in a report on Thursday, July 31st. Mizuho set a $210.00 price target on Align Technology in a report on Thursday, July 31st. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $140.00 price objective (down from $215.00) on shares of Align Technology in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Align Technology currently has an average rating of “Hold” and an average price target of $200.00.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.